Position in AMGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$5,662,832
+$437,508 QoQ
Shares Held
15,638
+5.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#776
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEVEL FOUR ADVISORY SERVICES, LLC holds $97,082,688 across 12 Drug Manufacturers - General names. AMGN ranks #6 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
135,146 | $34,008,139 | |
| 2 | JNJ |
Johnson & Johnson
|
65,905 | $16,737,892 | |
| 3 | NVO |
Novo Nordisk A S
|
197,413 | $9,463,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
73,273 | $9,415,580 | |
| 5 | LLY |
ELI LILLY & Co
|
7,377 | $8,848,195 | |
| 6 | AMGN |
Amgen Inc
This page
|
15,638 | $5,662,832 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
31,194 | $3,941,049 | |
| 8 | AZN |
Astrazeneca PLC
|
15,186 | $2,879,569 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,662,832 | 15,638 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $5,225,324 | 14,851 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,555,827 | 13,919 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,953,339 | 14,009 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,806,190 | 13,632 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,169,473 | 13,383 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,514,730 | 13,485 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $4,242,539 | 13,167 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,969,989 | 12,706 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,125,338 | 3,958 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,139,983 | 3,958 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,036,876 | 3,858 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $970,671 | 4,372 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $1,060,799 | 4,388 | Shares | Sole | 2023-06-05 | |
| 2022-12-31 | $979,647 | 3,730 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $706,178 | 3,133 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $745,471 | 3,064 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $789,058 | 3,263 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $953,197 | 4,237 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $401,695 | 1,889 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $1,023,018 | 4,197 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,080,333 | 4,342 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $995,093 | 4,328 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,045,614 | 4,114 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $1,152,411 | 4,886 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $890,187 | 4,391 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||